Attached files

file filename
EX-31.2 - Imerjn Inc.ex312medora.htm
EX-32.1 - Imerjn Inc.ex321medora.htm
10-K - Imerjn Inc.xumanii_10krevidoc.htm


I, Alexandre Frigon, the President, CEO of Medora Corp. (the Registrant), certify that;


I have reviewed this quarterlyl Report on Form 10-K of the Registrant;






Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;






Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;






I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934) for the Registrant and have:






Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the Registrant is made known to me by others within those entities, particularly during the period in which this report is being prepared;







Evaluated the effectiveness of the Registrants disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and







Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and







I have disclosed, based on my most recent evaluation of the internal control over financial reporting, to the Registrants auditors and the audit committee of Registrants board of directors (or persons performing the equivalent functions):






All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrants ability to record, process, summarize and report financial information; and







Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrants internal control over financial reporting.



December 7, 2012



/s/Alexandre Frigon


Alexandre Frigon

President, CEO


and Chief Financial Officer